Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors

by Elizabeth A. Thomas
Published 2014-05-01

Plasma NfL as a prognostic biomarker for enriching HD-ISS stage 1 categorisation: a cross-sectional studyResearch in context

by Georgia M. Parkin, Elizabeth A. Thomas, Jody Corey-Bloom
Published 2023-07-01

Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease

by Paula A. Desplats, James R. Lambert, Elizabeth A. Thomas
Published 2008-09-01

Mapping neurodegeneration across the Huntington's disease spectrum: a five-year longitudinal analysis of plasma neurofilament lightResearch in context

by Georgia M. Parkin, Elizabeth A. Thomas, Jody Corey-Bloom
Published 2024-06-01

Evaluation of Biochemical and Epigenetic Measures of Peripheral Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker in Huntington’s Disease Patients

by Ashley Gutierrez, Jody Corey-Bloom, Elizabeth A. Thomas, Paula Desplats, Paula Desplats, Paula Desplats
Published 2020-01-01

Salivary levels of total huntingtin are elevated in Huntington’s disease patients

by Jody Corey-Bloom, Ameera S. Haque, Sungmee Park, Ajay S. Nathan, Robert W. Baker, Elizabeth A. Thomas
Published 2018-05-01

Genome-wide identification of Bcl11b gene targets reveals role in brain-derived neurotrophic factor signaling.

by Bin Tang, Pietro Di Lena, Lana Schaffer, Steven R Head, Pierre Baldi, Elizabeth A Thomas
Published 2011-01-01

Uric Acid as a Potential Peripheral Biomarker for Disease Features in Huntington’s Patients

by Jody Corey-Bloom, Ameera Haque, Sameer Aboufadel, Chase Snell, Ryan S. Fischer, Steven W. Granger, Douglas A. Granger, Douglas A. Granger, Douglas A. Granger, Douglas A. Granger, Douglas A. Granger, Elizabeth A. Thomas, Elizabeth A. Thomas
Published 2020-03-01

Effectiveness of Intermittent Fasting and Time-Restricted Feeding Compared to Continuous Energy Restriction for Weight Loss

by Corey A. Rynders, Elizabeth A. Thomas, Adnin Zaman, Zhaoxing Pan, Victoria A. Catenacci, Edward L. Melanson
Published 2019-10-01

Low density lipoprotein receptor-related protein and apolipoprotein E expression is altered in schizophrenia

by Andrew S Gibbons, Andrew S Gibbons, Elizabeth A Thomas, Elizabeth Scarr, Elizabeth Scarr, Brian Dean, Brian Dean, Brian Dean
Published 2010-07-01

Gene expression profiling of R6/2 transgenic mice with different CAG repeat lengths reveals genes associated with disease onset and progression in Huntington's disease

by Bin Tang, Tamara Seredenina, Giovanni Coppola, Alexandre Kuhn, Daniel H. Geschwind, Ruth Luthi-Carter, Elizabeth A. Thomas
Published 2011-06-01

Propensity to obesity impacts the neuronal response to energy imbalance

by Marc-Andre eCornier, Marc-Andre eCornier, Kristina Legget McFadden, Elizabeth A Thomas, Elizabeth A Thomas, Jamie L Bechtell, Jamie L Bechtell, Daniel H Bessesen, Daniel H Bessesen, Jason R Tregellas, Jason R Tregellas, Jason R Tregellas
Published 2015-02-01

The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington's Disease Mice.

by Haiqun Jia, Ying Wang, Charles D Morris, Vincent Jacques, Joel M Gottesfeld, James R Rusche, Elizabeth A Thomas
Published 2016-01-01

Salivary S100 calcium-binding protein beta (S100B) and neurofilament light (NfL) after acute exposure to repeated head impacts in collegiate water polo players

by Derek C. Monroe, Elizabeth A. Thomas, Nicholas J. Cecchi, Douglas A. Granger, James W. Hicks, Steven L. Small
Published 2022-03-01

Salivary Huntingtin protein is uniquely associated with clinical features of Huntington’s disease

by Georgia M. Parkin, Jody Corey-Bloom, Chase Snell, Haileigh Smith, Angela Laurenza, Manuel Daldin, Alberto Bresciani, Elizabeth A. Thomas
Published 2023-01-01

Improving lifestyle obesity treatment during the COVID‐19 pandemic and beyond: New challenges for weight management

by Ann E. Caldwell, Elizabeth A. Thomas, Corey Rynders, Brooke Dorsey Holliman, Cathryn Perreira, Danielle M. Ostendorf, Victoria A. Catenacci
Published 2022-02-01

The effects of early time restricted eating plus daily caloric restriction compared to daily caloric restriction alone on continuous glucose levels

by Adnin Zaman, Laura Grau, Rebecca Jeffers, Sheila Steinke, Victoria A. Catenacci, Marc‐Andre Cornier, Corey A. Rynders, Elizabeth A. Thomas
Published 2024-02-01

Levels of Interleukin-6 in Saliva, but Not Plasma, Correlate with Clinical Metrics in Huntington’s Disease Patients and Healthy Control Subjects

by Jody Corey-Bloom, Ryan S. Fischer, Aeri Kim, Chase Snell, Georgia M. Parkin, Douglas A. Granger, Steven W. Granger, Elizabeth A. Thomas
Published 2020-09-01

Glycolipid and ganglioside metabolism imbalances in Huntington's disease

by Paula A. Desplats, Christine A. Denny, Kristi E. Kass, Tim Gilmartin, Steven R. Head, J. Gregor Sutcliffe, Thomas N. Seyfried, Elizabeth A. Thomas
Published 2007-09-01

Later Meal and Sleep Timing Predicts Higher Percent Body Fat

by Elizabeth A. Thomas, Adnin Zaman, Marc-Andre Cornier, Victoria A. Catenacci, Emma J. Tussey, Laura Grau, Jaron Arbet, Josiane L. Broussard, Corey A. Rynders
Published 2020-12-01